#Nephrogen
NKF Innovation Fund Invests in Nephrogen to Advance One-Time Gene Editing Therapies for Kidney Disease
Investment supports advancement of a delivery platform built to solve the barrier that has kept genetic medicines out of the kidney, and a lead program in polycystic kidney disease. NEW YORK, Oct. 6, 2026 /PRNewswire/ -- The National Kidney Foundation (NKF) today announced an investment from the NKF Innovation Fund in Nephrogen, a biotechnology company developing one-time gene editing therapies for kidney disease. Gene therapy has opened new possibilities for treating and potentially curing diseases by addressing their underlying genetic causes. But bringing those advances to kidney disease has proven particularly challenging. According to the Q2 2026 landscape report from the American Society of Gene and Cell Therapy (ASGCT), 931 gene therapies are approved, in clinical trials, or awaiting regulatory approval worldwide. No gene therapy has been approved for a kidney disease, and only one program designed to target kidney cells is known to have entered clinical trials. The kidney's complex structure and filtration barrier make it difficult for gene therapy delivery vehicles to reach their target cells, and kidney disease can originate in more than 15 distinct cell types. Nephrogen's NeFIND™ platform, which combines artificial intelligence with high-throughput screening to discover new gene therapy delivery vehicles, aims to address...
www.biospace.com
October 7, 2026 at 6:45 AM
Биотехнологическая компания Nephrogen объединяет ИИ и генные методы лечения для обратного развития болезни почек — ознакомьтесь с этим на TechCrunch Disrupt 2025

Telegram ИИ Дайджест
#ai #news
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025
techcrunch.com
October 28, 2025 at 4:26 PM
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025

When Demetri Maxim was seven years old, his mother’s kidneys stopped working. She was put on dialysis, which meant that she had to go to the hospital four times a week to have her…
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025
When Demetri Maxim was seven years old, his mother’s kidneys stopped working. She was put on dialysis, which meant that she had to go to the hospital four times a week to have her blood filtered by a machine since her own kidneys could no longer function independently. Two years later, Maxim’s mother received a kidney transplant. Although the surgery was successful and allowed her to lead a relatively normal life, it wasn’t the end of his family’s struggle with kidney disease.
nexttech-news.com
October 27, 2025 at 9:36 PM
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025 | TechCrunch
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025 | TechCrunch - The Republic News
When Demetri Maxim was seven years old, his mother’s kidneys stopped working. She was put on dialysi
therepublic.pk
October 27, 2025 at 6:17 PM
AI와 유전자 치료로 신장질환 완치에 도전하는 5가지 혁신 기술

네프로젠(Nephrogen)이 AI와 CRISPR 유전자 편집 기술을 결합해 신장질환 치료의 새로운 패러다임을 제시하고 있어요. 기존 치료법과 달리 질병을 근본적으로 역전시키는 혁

bit.ly/49of58S
October 27, 2025 at 11:40 PM
Neues aus der Forschung: Publikationen, Studien und Forschungsprojekte aus dem UKE
Bundesforschungsministerium fördert Verbundprojekt zur intraoperativen Analyse von entferntem Tumorgewebe | DFG verlängert Sonderforschungsbereich zur Nephrogen...
weiterlesen
November 27, 2024 at 11:13 AM
This year’s Startup Battlefield runner-up is Nephrogen!

They’re a biotech startup that has created a delivery mechanism for getting gene-editing medicines into in kidneys. Plus, its founder will participate in their clinical study.

Learn more here, from #TechCrunchDisrupt: https://tcrn.ch/4nyfclV
October 30, 2025 at 12:21 AM
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025

When Demetri Maxim was seven years old, his mother’s kidneys stopped working. She was put on dialysis, which meant that she had to go to the hospital four times a week to have her…
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025
When Demetri Maxim was seven years old, his mother’s kidneys stopped working. She was put on dialysis, which meant that she had to go to the hospital four times a week to have her blood filtered by a machine since her own kidneys could no longer function independently. Two years later, Maxim’s mother received a kidney transplant. Although the surgery was successful and allowed her to lead a relatively normal life, it wasn’t the end of his family’s struggle with kidney disease.
nexttech-news.com
October 27, 2025 at 9:36 PM
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025

When Demetri Maxim was seven years old, his mother’s kidneys stopped working. She was put on dialysis, which meant that she had to go to the hospital four times a week to have her…
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025
When Demetri Maxim was seven years old, his mother’s kidneys stopped working. She was put on dialysis, which meant that she had to go to the hospital four times a week to have her blood filtered by a machine since her own kidneys could no longer function independently. Two years later, Maxim’s mother received a kidney transplant. Although the surgery was successful and allowed her to lead a relatively normal life, it wasn’t the end of his family’s struggle with kidney disease.
virtualnewss360.com
October 27, 2025 at 7:08 PM
Parts 1-3/3 — EFTA00520772.jpg
#epsteinweb #efta00520772
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
May 3, 2026 at 11:26 AM
Here are the five finalists for TechCrunch Disrupt 2025’s Startup Battlefield

🔥 Discover this awesome post from TechCrunch 📖 📂 Category: Startups,Charter Space,Glīd Technologies,MacroCycle,Nephrogen,Startup Battlefield,TechCrunch Disrupt,TechCrunch Disrupt 2025,Unlisted Homes ✅ Here’s what you’ll…
Here are the five finalists for TechCrunch Disrupt 2025’s Startup Battlefield
🔥 Discover this awesome post from TechCrunch 📖 📂 Category: Startups,Charter Space,Glīd Technologies,MacroCycle,Nephrogen,Startup Battlefield,TechCrunch Disrupt,TechCrunch Disrupt 2025,Unlisted Homes ✅ Here’s what you’ll learn: After two days full of live demos and pitches, it's time to announce the five finalists for this year's Startup Battlefield. These finalists were chosen from an initial pool of thousands of applicants, with TechCrunch's editorial team narrowing the field to 200 companies who all joined us here at Disrupt, with the top 20 competing on the Disrupt Stage.
viralpique.com
October 29, 2025 at 1:02 AM
Biotech Nephrogen combines AI with gene therapy to reverse kidney disease – check it out at TechCrunch Disrupt 2025

🔥 Discover this trending post from TechCrunch 📖 📂 Category: Startups,Biotech & Health,AI,TechCrunch Disrupt,Startup Battlefield,TechCrunch Disrupt 2025,Nephrogen 📌 Main takeaway:…
Biotech Nephrogen combines AI with gene therapy to reverse kidney disease – check it out at TechCrunch Disrupt 2025
🔥 Discover this trending post from TechCrunch 📖 📂 Category: Startups,Biotech & Health,AI,TechCrunch Disrupt,Startup Battlefield,TechCrunch Disrupt 2025,Nephrogen 📌 Main takeaway: When Dmitry Maxim was seven years old, his mother's kidneys stopped working. She was put on dialysis, which meant she had to go to hospital four times a week to have her blood filtered by a machine because her kidneys could no longer function independently.
viralpique.com
October 27, 2025 at 7:10 PM
Biotech Nephrogen Combines AI and Gene Therapy to Reverse Kidney Disease

𝗙𝗼𝗿 𝗺𝗼𝗿𝗲 𝗱𝗲𝘁𝗮𝗶𝗹𝘀 𝘃𝗶𝘀𝗶𝘁 ➜ www.techticia.com/2025/10/biot...
October 29, 2025 at 8:28 AM
"After three years of development, Maxim claims Nephrogen has succeeded in creating a delivery mechanism that is 100 times more efficient at transporting medicine to the kidney than the vehicles currently approved by the FDA." techcrunch.com/2025/10/27/b...
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025 | TechCrunch
Latest
techcrunch.com
October 30, 2025 at 12:40 PM
Startup biotechnologiczny Nephrogen, założony przez Demetriego Maxima, prezentuje na TechCrunch Disrupt 2025 przełomową technologię łączącą sztuczną inteligencję z terapią genową. Celem jest odwrócenie dziedzicznych chorób nerek, takich jak wielotorbielowatość nerek (PKD), oferując nadzieję…
Nephrogen: nowa era w leczeniu chorób nerek dzięki AI i terapii genowej
Startup biotechnologiczny Nephrogen, założony przez Demetriego Maxima, prezentuje na TechCrunch Disrupt 2025 przełomową technologię łączącą sztuczną inteligencję z terapią genową. Celem jest odwrócenie dziedzicznych chorób nerek, takich jak wielotorbielowatość nerek (PKD), oferując nadzieję milionom pacjentów.
aisight.pl
October 28, 2025 at 6:30 AM
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025

Although Maxim was convinced that gene therapy could reverse PKD, the biggest hurdle was creating a mechanism to deliver the drugs directly to the diseas…

Telegram AI Digest
#ai #news
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025
Although Maxim was convinced that gene therapy could reverse PKD, the biggest hurdle was creating a mechanism to deliver the drugs directly to the diseased cells.
techcrunch.com
October 28, 2025 at 4:32 PM
2 Startup Battlefield finalists at TechCrunch Disrupt 2025 create #SocialImpact. Learn more about MacroCycle (cheap recycled plastic) and Nephrogen (improved kidney disease treatments)
https://techcrunch.com/2025/10/28/here-are-the-5-startup-battlefield-finalists-at-techcrunch-disrupt-2025/
Here are the 5 Startup Battlefield finalists at TechCrunch Disrupt 2025 | TechCrunch
After two days full of live demos and pitches, it's time to announce the five finalists at this year's Startup Battlefield.
techcrunch.com
October 31, 2025 at 12:35 PM